teams of distinction
(2019-2022)

 

Reducing Medical Errors and Enhancing Patient Care through Pathology Lead Strategic Activation of Point-of-Care Testing in an Emerging Market 
Aga Khan University Hospital, Nairobi, Kenya

 

Early diagnosis of maternal cytomegalovirus for improved management and reduced risk of fetal transmission and complications
National Reference Center for Herpesvirus, University Hospital Center, Limoges, France

 

Improving Quality, Patient Care & Experience, while Lowering Costs Through Enhanced Laboratory Stewardship
Cleveland Clinic, Cleveland, Ohio, United States

 

Novel Collaborative Approach among Public and Private Sectors for Streamlined SARS-CoV-2 Testing towards Optimized Patient Outcome during Covid-19 Pandemic 
Dubai Health Authority, United Arab Emirates

 

IDENTIFYING UNTREATED HEPATITIS B AND HEPATITIS C VIA OPT-OUT SCREENING PROGRAM IN URBAN ED SETTINGS
Guy's and St Thomas’ NHS Foundation Trust and Viapath Pathology Analytics, London, United Kingdom

 

THE GLOBAL IMPACT OF TROPONIN AND BIOMARKERS ON ISCHEMIC MYOCARDIAL INJURY AND SURGICAL CARE
Hamilton Health Sciences/Population Health Research Institute, Ontario, Canada

 

EARLY DETECTION AND MANAGEMENT OF GESTATIONAL DIABETES MELLITUS FOR IMPROVED OUTCOMES OF MOTHERS AND THEIR BABIES
Hospital Clinico San Carlos, Madrid, Spain

 

REDUCING CATASTROPHIC ADVERSE EVENTS IN PATIENTS WITH HEMORRHAGIC SHOCK THROUGH EARLY RECOGNITION OF RISK AND SYSTEM-WIDE AUTOMATIC ALERTS
Hospital Israelita Albert Einstein, São Paulo, Brazil

 

REDUCING POST-OPERATIVE COMPLICATIONS IN CARDIAC SURGERY PATIENTS
Hospital Virgen Macarena, Sevilla, Spain

 

IMPROVING MORBIDITY AND MORTALITY IN PATIENTS WITH SEPSIS
King Abdulaziz Medical City, Jeddah, Saudi Arabia

 

AVOIDING INSUFFICIENT THERAPIES AND OVERDOSING WITH CO-REPORTING EGFRS FOR PERSONALIZED DRUG THERAPY AND IMPROVED OUTCOME
Marienhospital, Stutgart, Germany

 

Preventing cardiovascular disease in a large client population through proactive, cost-effective and enhanced identificaiton of cardiovascular risk using a novel laboratory test
Medcan Healthcare Management Inc., Ontario, Canada

 

ENHANCED RESOURCE UTILIZATION, REDUCED WASTE, AND EXPEDITED TRANSPLANTATION THROUGH REAL-TIME DONOR SCREENING FOR INFECTIOUS DISEASE
Mid America Transplant, St. Louis, Missouri, United States

 

Use of Fecal Immunochemical Tests (FIT) Unlocks the Door to Efficient and Effective Investigation of Patients with New Bowel Symptoms
NHS Tayside, Dundee, United Kingdom

 

Reduction of Inpatient Daily Blood Draws with Data Science and Clinical Collaboration 
St. Paul’s Hospital, British Columbia, Canada

 

FH ALERT: identification of patients with familial hypercholesterolemia (FH) by using the expertise and resources of the clinical laboratory
SYNLAB Holding Deutschland GmbH, Mannheim, Germany

 

Improved Safety for Patients with Indeterminant Pulmonary Nodules through Optimized Diagnostic Pathways for Lung Cancer 
The First Affiliated Hospital, Sun Yat-sen University, Guangdong Province, China

 

Improving Clinical and Quality Outcomes for Prenatal Care – A Clinical Laboratory Driven Initiative
TriCore Reference Laboratories, Albuquerque, New Mexico, United States

 

Addressing COVID clinical and translational challenges via mulitdiscipline integrated diagnostics networks
UHCW NHS Trust & Warwick Medical School, Coventry, United Kingdom

 

Enhanced Identification and Care for Patients with Undetected HCV and/or HIV via Opt-Out ED Screening with Active Education and Linkage to Care 
University Alabama-Birmingham Hospital, Alabama, United States

 

GETTING TO ZERO HARM IN CONTROLLED SUBSTANCE PRESCRIBING: INCREASING THE ACCURACY OF PRESCRIPTION COMPLIANCE MONITORING THROUGH ENHANCED DRUG TESTING SUPPORT
University Hospitals Cleveland, Cleveland, Ohio, United States

 

Optimization of heart failure management using biomarkers in patients with low risk for rehospitalization
University Medical Center Groningen, Netherlands